This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrough so advanced, it’s going to make ChatGPT look like VHS. But what’s even more unbelievable? I believe it’ll make Nvidia’s meteoric rise look like a backyard bottle rocket.

Click here and I’ll tell you everything you need to know.

Cheryl Scott Biography and Net Worth

Director of Progyny

Cheryl Scott has served as a member of our board of directors since October 2019. Ms. Scott has served since July 2016 as the Main Principal of the McClintock Scott Group. From June 2006 to July 2016, Ms. Scott served as Senior Advisor to the Bill & Melinda Gates Foundation. Previously, she served as President and Chief Executive Officer of the Seattle-based Group Health Cooperative for eight years. Ms. Scott has served as a member of the board of directors of Evolent Health, Inc. since November 2015. She also currently serves on a variety of private and not-for-profit boards. She was a member of the board of directors of Recreational Equipment Incorporated (REI) from 2005 to 2017, and served as the board chairperson from 2015 to 2017. Ms. Scott received her bachelor’s degree in communications and master’s degree in health management from the University of Washington, and is currently a Clinical Professor of Health Services at the University of Washington. We believe that Ms. Scott is qualified to serve on our board of directors because of her extensive career in healthcare, leadership and corporate governance, including her tenure as the Chief Executive Officer of Group Health Cooperative.

What is Cheryl Scott's net worth?: The estimated net worth of Cheryl Scott is at least $157,427.82 as of June 28th, 2024. Ms. Scott owns 10,098 shares of Progyny stock worth more than $157,428 as of December 3rd. This net worth estimate does not reflect any other assets that Ms. Scott may own. Learn More about Cheryl Scott's net worth.
How do I contact Cheryl Scott?: The corporate mailing address for Ms. Scott and other Progyny executives is 1359 BROADWAY, NEW YORK NY, 10018. Progyny can also be reached via phone at 212-888-3124 and via email at [email protected]. Learn More on Cheryl Scott's contact information.
Has Cheryl Scott been buying or selling shares of Progyny?: Cheryl Scott has not been actively trading shares of Progyny during the last ninety days. Most recently, Cheryl Scott sold 1,462 shares of the business's stock in a transaction on Friday, June 28th. The shares were sold at an average price of $28.39, for a transaction totalling $41,506.18. Following the completion of the sale, the director now directly owns 10,098 shares of the company's stock, valued at $286,682.22. Learn More on Cheryl Scott's trading history.
Who are Progyny's active insiders?: Progyny's insider roster includes Peter Anevski (COO), Jennifer Bealer (EVP), Kevin Gordon (Director), Lisa Greenbaum (EVP), Mark Livingston (CEO), Norman Payson (Director), David Schlanger (CEO), Cheryl Scott (Director), and Michael Sturmer (President). Learn More on Progyny's active insiders.
Are insiders buying or selling shares of Progyny?: In the last twelve months, insiders at the sold shares 19 times. They sold a total of 397,848 shares worth more than $14,917,056.68. The most recent insider tranaction occured on July, 16th when President Michael E Sturmer sold 9,030 shares worth more than $270,900.00. Insiders at Progyny own 12.3% of the company. Learn More about insider trades at Progyny.
Information on this page was last updated on 7/16/2024.

Cheryl Scott Insider Trading History at Progyny

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
6/28/2024	Sell	1,462	$28.39	$41,506.18	10,098
6/27/2023	Sell	1,170	$37.27	$43,605.90	9,744
11/8/2021	Sell	2,000	$66.30	$132,600.00

Cheryl Scott Buying and Selling Activity at Progyny

Progyny Company Overview

Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides assistance service programs where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.

Today's Range

Now: $15.24

$15.15

$15.59

50 Day Range

MA: $15.79

$13.67

$17.18

2 Week Range

Now: $15.24

$13.39

$42.08

Volume

140,619 shs

Average Volume

1,397,080 shs

Market Capitalization

$1.30 billion

P/E Ratio

26.28

Dividend Yield

N/A

Beta

1.35

Missed Nvidia? Watch this ASAP

From Brownstone Research | Ad